Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease

Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)–induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Aβ-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Aβ to mitochondrial toxicity. Aβ interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Aβ-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Aβ interaction and suppresses Aβ-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Aβ-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Aβ interaction may be a therapeutic target in AD.

[1]  L. Tjernberg,et al.  Binding of amyloid β‐peptide to mitochondrial hydroxyacyl‐CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease , 1999 .

[2]  C. Masters,et al.  Alzheimer's disease: The ins and outs of amyloid-β , 1997, Nature.

[3]  T. Emery,et al.  Peptides , 1964, Peptides.

[4]  J. Hardy,et al.  Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.

[5]  J.L.O'L.,et al.  Chemical Pathology of the Nervous System (Proceedings of the Third International Neurochemical Symposium held at Strasbourg, 1958) , 1962, Neurology.

[6]  M. Weisfeldt,et al.  Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. , 1992, Journal of the American College of Cardiology.

[7]  M. Mattson Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease. , 2002, International review of neurobiology.

[8]  Xi Chen,et al.  An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease , 1997, Nature.

[9]  Yitao Liu,et al.  Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.

[10]  S. Kish,et al.  Mitochondria in Alzheimer's disease. , 2002, International review of neurobiology.

[11]  M. Frosch,et al.  Amyloid beta -peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress. , 2000, The Journal of biological chemistry.

[12]  H. Vinters,et al.  Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice , 2003, Neurological research.

[13]  George Perry,et al.  Role of mitochondrial dysfunction in Alzheimer's disease , 2002, Journal of neuroscience research.

[14]  A. Ferrús,et al.  scully, an Essential Gene of Drosophila, is Homologous to Mammalian Mitochondrial Type II l-3-hydroxyacyl-CoA Dehydrogenase/Amyloid-β Peptide-binding Protein , 1998, The Journal of cell biology.

[15]  O. Arancio,et al.  Calpain inhibitors , 2002, Journal of Molecular Neuroscience.

[16]  M. Banfield,et al.  Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD). , 2000, Journal of molecular biology.

[17]  Steven G. Clarke,et al.  Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity* , 1999, The Journal of Biological Chemistry.

[18]  J. Blass Cerebrometabolic abnormalities in Alzheimer's disease , 2003, Neurological research.

[19]  M. E. Beall U.S. patent and trademark office , 1997 .

[20]  S. Dowdy,et al.  TAT-mediated protein transduction into mammalian cells. , 2001, Methods.

[21]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[22]  J. Blass Glucose/mitochondria in neurological conditions. , 2002, International review of neurobiology.

[23]  C. Oliveira,et al.  Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative Diseases , 2003, Neurochemical Research.

[24]  G. Perry,et al.  Book Review: Is Alzheimer’s Disease a Mitochondrial Disorder? , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.